ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Damage Index"

  • Abstract Number: 0160 • ACR Convergence 2022

    Sarcopenia in Myositis Patients: A Marker of Muscle Damage Associated with Myositis Severity and Disability

    Margherita Giannini1, Léa Debrut2, Anne-Laure Charles2, Mégane Pizzimenti2, Rose-Marie Javier3, Bernard Geny4 and Alain Meyer1, 1Service de Physiologie et explorations fonctionnelles, CHU, Strasbourg ; Centre de Référence des Maladies Autoimmunes Rares, CHU, Strasbourg ; UR3072, Centre de Recherche en Biomédecine, University of Strasbourg, Strasbourg, France, 2UR3072 Centre de Recherche en Biomédecine, University of Strasbourg, Strasbourg, France, 3Service de Rhumatologie, Centre de Référence des Maladies Autoimmunes Rares, University Hospital of Strasbourg, Strasbourg, France, 4Service de Physiologie et explorations fonctionnelles, CHU, Strasbourg ; UR3072 Centre de Recherche en Biomédecine, University of Strasbourg, Strasbourg, France

    Background/Purpose: Myositis are autoimmune diseases characterized by muscle inflammation and weakness. Even when disease is no longer active, a great proportion of patients does not…
  • Abstract Number: 0343 • ACR Convergence 2022

    Severe Non-adherence to Hydroxychloroquine Is Associated with Flares, Early Damage, and Mortality in Systemic Lupus Erythematosus: Data from 660 Patients from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Yann Nguyen1, Benoît BLanchet2, Murray Urowitz3, John Hanly4, Caroline Gordon5, Sang-Cheol Bae6, Juanita Romero-Diaz7, Jorge Sanchez-Guerrero8, Ann E Clarke9, Sasha Bernatsky10, Daniel Wallace11, David Isenberg12, Anisur Rahman13, Joan Merrill14, Paul R Fortin15, Dafna Gladman16, Ian N. Bruce17, Michelle Petri18, Ellen M. Ginzler19, Mary Anne Dooley20, Rosalind Ramsey-Goldman21, Susan Manzi22, Andreas Jönsen23, Graciela Alarcón24, Ronald van Vollenhoven25, Cynthia Aranow26, Veronique Le Guern27, Meggan Mackay26, Guillermo Ruiz-Irastorza28, S. Sam Lim29, Murat Inanc30, Kenneth C Kalunian31, Soren Jacobsen32, Christine Peschken33, Diane Kamen34, Anca Askanase35, Jill Buyon36 and Nathalie Costedoat-Chalumeau37, 1AP-HP.Centre Universit Paris Cit Hôpital Cochin, Montmorency, France, 2Biologie du médicament-Toxicologie, AP-HP Centre – Hôpital Cochin, Université Paris Cité, Paris, France, Paris, 3University of Toronto, University Health Network, Schroeder Arthritis Institute, Toronto, ON, Canada, 4Division of Rheumatology, Queen Elizabeth II Health Sciences Center (Nova Scotia Rehabilitation Site) and Dalhousie University, Halifax, NS, Canada, 5Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 6Hanyang University Medical Center, Seoul, Republic of Korea, 7Instituto Nacional de Ciencias Medicas y Nutricion SZ, Ciudad de México, Mexico, 8Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, ON, Canada, 9University of Calgary, Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada, 10Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 11Cedars-Sinai Medical Center, Los Angeles, CA, 12University College London, London, United Kingdom, 13Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom, 14Oklahoma Medical Research Foundation, Oklahoma City, OK, 15Centre ARThrite - CHU de Québec - Université Laval, Québec, QC, Canada, 16Toronto Western Hospital, Schroeder Arthritis Institute, Toronto, ON, Canada, 17Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom, 18Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, MD, 19SUNY Downstate Health Sciences University, Department of Medicine, Brooklyn, NY, 20Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 21Northwestern University Feinberg School of Medicine, Chicago, USA, Chicago, IL, 22Allegheny Health Network, Lupus Center of Excellence, Wexford, PA, 23Lund University, Lund, Sweden, 24The University of Alabama at Birmingham, Oakland, 25Amsterdam University Medical Centers, Amsterdam, Netherlands, 26Feinstein Institutes for Medical Research, Manhasset, NY, 27Hôpital Cochin, Paris, France, 28Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Spain, 29Emory University, Atlanta, GA, 30Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istambul, Turkey, 31University of California San Diego School of Medicine, La Jolla, 32Rigshospitalet, Copenhagen, Denmark, 33University of Manitoba, Winnipeg, MB, Canada, 34Medical University of South Carolina, Charleston, SC, 35Columbia University Medical Center, New York, NY, 36NYU Grossman School of Medicine, New York, NY, 37Inserm DR Paris 5, Paris, France

    Background/Purpose: The efficacy of antimalarials, especially hydroxychloroquine (HCQ), in preventing flares of systemic lupus erythematosus (SLE) is well demonstrated, but its effectiveness is impaired by…
  • Abstract Number: 0541 • ACR Convergence 2022

    Prevalence of Venous Thrombo-Embolism in Lupus Nephritis and Associated Risk Factors

    Tara Tofighi, Jiandong Su and Zahi Touma, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada

    Background/Purpose: Patients with SLE have an increased risk of developing venous thrombo-embolism (VTE) based on several cohort studies, accounting for significant morbidity and mortality. Lupus…
  • Abstract Number: 0677 • ACR Convergence 2022

    Obstructive Sleep Apnea in Primary Antiphospholipid Syndrome Impacts Damage Accrual

    Gustavo Balbi1, Flavio Victor Signorelli2, Ana Paula Gandara3, Indira Azam3, Dilson Marreiros3, Luciano Drager3 and Danieli Castro Oliveira de Andrade4, 1Universidade de São Paulo, São Paulo, Brazil, 2Universidade do Estado do Rio de Janeiro, Rio De Janeiro, Brazil, 3University of São Paulo, São Paulo, Brazil, 4Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Obstructive sleep apnea (OSA) has been associated with an increased risk of thrombotic-related events, such as myocardial infarction and cerebrovascular diseases in the general…
  • Abstract Number: 0982 • ACR Convergence 2022

    Effect of Cumulative Hydroxychloroquine Dose on Prevention of Damage Progression and Cardiovascular Events in Patients with Systemic Lupus Erythematosus

    Jordan Jacquez1, Lisa Zhu1, Manpreet Singh1, Caroline Siegel2, Lori Sahakian1, Brian Skaggs1, Jennifer Grossman1 and Maureen McMahon1, 1University of California Los Angeles, Los Angeles, CA, 2Hospital for Special Surgery, New York, NY

    Background/Purpose: Hydroxychloroquine (HCQ) has demonstrated benefit in multiple outcomes in systemic lupus erythematosus (SLE), including disease activity, flare rates, survival, and thrombotic events. Previous studies,…
  • Abstract Number: 1528 • ACR Convergence 2022

    Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) and Organ Damage: Data from the SENSCIS Trial

    Janet Pope1, Susanna Proudman2, Wendy Stevens3, Joerg Henes4, Rozeta Simonovska5, Margarida Alves6 and Yannick Allanore7, 1University of Western Ontario, London, ON, Canada, 2Rheumatology Unit, Royal Adelaide Hospital, and Discipline of Medicine, University of Adelaide, Adelaide, Australia, 3Department of Rheumatology, St Vincent’s Hospital, Melbourne, Australia, Melbourne, Australia, 4Center for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases (INDIRA), University Hospital Tübingen, Tübingen, Germany, 5mainanalytics GmbH, Sulzbach (Taunus), Germany, Sulzbach (Taunus), Germany, 6Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, 7Department of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France, Paris, France

    Background/Purpose: The Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI) was developed to quantify organ damage in patients with SSc. We assessed outcomes in the SENSCIS…
  • Abstract Number: 1562 • ACR Convergence 2022

    Validation of Behçet’s Disease Overall Damage Index (BODI) for Retrospective Studies and a Proposal for Modification

    Yeliz Yagiz Ozogul1, Yesim Ozguler2, Didar Ucar3, Ugur Uygunoglu4, Zekayi Kutlubay5, Vedat Hamuryudan6 and gulen Hatemi7, 1Istanbul University-Cerrahpaşa, Cerrahpaşa Medical School, Department of Internal Medicine, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, New York, NY, 3Istanbul University-Cerrahpaşa, Cerrahpaşa Medical School, Department of Ophthalmology, Istanbul, Turkey, 4Istanbul University-Cerrahpaşa, Cerrahpaşa Medical School, Department of Neurology, Istanbul, Turkey, 5Istanbul University-Cerrahpaşa, Cerrahpaşa Medical School, Department of Dermatology, Istanbul, Turkey, 6Istanbul University-Cerrahpaşa, Cerrahpaşa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 7Istanbul University-Cerrahpaşa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

    Background/Purpose: Damage accrual in Behçet syndrome (BS) may progress over the years and an index that can be scored using retrospective data may be useful…
  • Abstract Number: 1602 • ACR Convergence 2022

    Fibroblast Activation Protein (FAP) PET-CT for Depicting Inflammatory Joint Damage in Patients with Psoriatic Arthritis

    Simon Rauber1, Hashem Mohammadian2, Chrstian Schmidkonz3, Armin Atzinger3, Maria Gabriella Raimondo1, Hannah Labinsky4, Christoph Treutlein2, Johannes Knitza1, Simone Maschauer2, Frank Roemer5, Olaf Prante2, Torsten Kuwert3, Juan Canete6, Georg Schett7 and Andreas Ramming1, 1Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2Friedrich-Alexander-University (FAU) Erlangen-Nürnberg, Erlangen, Germany, 3Friedrich-Alexander University (FAU) Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 5Friedrich-Alexander University Erlangen Nürnberg, Erlangen, Germany, 6Unidad de Artritis Hospital Clinic, Barcelona, Spain, 7Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: Psoriatic arthritis (PsA) is characterized by substantial mesenchymal tissue activation in the context of inflammation leading to structural damage. Measuring mesenchymal tissue activation in…
  • Abstract Number: 1877 • ACR Convergence 2022

    Nailfold Videocapillaroscopic Abnormalities Correlate with Disease Activity Measures and Cutaneous Damage in Patients with Idiopathic Inflammatory Myopathies

    Diane Zisa1, Aliza Bloostein1, Deanna Jannat-Khah, DrPH, MSPH1, Maurizio Cutolo2, Vanessa Smith3 and David Fernandez1, 1Hospital for Special Surgery, New York, NY, 2Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genova, Italy, 3Department of Rheumatology, Ghent University Hospital – Department of Internal Medicine, Ghent University, Belgium – Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Gent, Belgium

    Background/Purpose: Nailfold videocapillaroscopy (NVC) is a non-invasive tool used to evaluate the microcirculation of patients with connective tissue diseases (CTDs). A specific combination of NVC…
  • Abstract Number: 2067 • ACR Convergence 2022

    Predictors of Organ Damage Accrual by Domains

    Rangi Kandane-Rathnayake1, Ning Li1, Vera Golder1, Worawit Louthrenoo2, Yi-Hsin Chen3, Jiacai Cho4, Aisha Lateef5, Laniyati Hamijoyo6, Luo Shue Fen7, Yeong-Jian Wu7, Sandra Navarra8, Leonid Zamora9, Zhanguo Li10, An Yuan11, Sargunan Sockalingam12, Yasuhiro Katsumata13, Masayoshi Harigai13, Yanjie Hao14, Zhouli Zhang15, Madelynn Chan16, Jun Kikuchi17, Tsutomu Takeuchi18, Shereen Oon19, Sang-Cheol Bae20, Fiona Goldblatt21, Sean O'Neill22, Kathy Gibson22, Kristine Ng23, Hui Nee Annie Law24, Duminda Basnayake25, Nicole Tugnet26, Sunil Kumar27, Cherica Tee28, Michael Tee28, Yoshiya Tanaka29, Chak Sing30, Mandana Nikpour31, Alberta Hoi32 and Eric Morand33, 1Monash University, Clayton, Australia, 2Chiang Mai University, Chiang Mai, Thailand, 3Taichung Veterans General Hospital, Taichung, Taiwan, 4National University Health System (NUHS), Singapore, Singapore, 5National University Hospital, Singapore, Singapore, 6Hasan Sadikin Hospital, Jakarta Selatan, Indonesia, 7Chang Gung Memorial Hospital, Taoyuan, Taiwan, 8University of Santo Tomas, Manila, Philippines, 9University of Santo Tomas Hospital, Manila, Philippines, 10People's Hospital, Peking University Health Science Center, Beijing, China, 11Peking University Health Science Center, Beijing, China, 12University of Malaya, Kuala Lumpur, Malaysia, 13Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan, 14The University of Melbourne, Melbourne, Australia, 15Peking University First Hospital, Beijing, China, 16Tan Tock Seng Hospital, Singapore, Singapore, 17Keio University, Tokyo, Japan, 18Keio University and Saitama Medical University, Tokyo, Japan, 19St Vincent's Hospital, Fitzroy, Australia, 20Hanyang University Medical Center, Seoul, Republic of Korea, 21Flinders Medical Centre, Adelaide, Australia, 22Liverpool Hospital, Sydney, Australia, 23North Shore Hospital, Auckland, New Zealand, 24Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore, 25Teaching Hospital Kandy, Kandy, Sri Lanka, 26Greenlane Clinical Centre, Auckland, New Zealand, 27Middlemore Hospital, Auckland, New Zealand, 28University of the Philippines, Quezon City, Philippines, 29University of Occupational and Environmental Health, Kitakyusyu Fukuoka, Japan, 30The University of Hong Kong, Pok Fu Lam, Hong Kong, 31The University of Melbourne at St. Vincent's Hospital Melbourne, Melbourne, Australia, 32Monash Health, Melbourne, Australia, 33Monash University, Victoria; Department of Rheumatology, Monash Health, Melbourne, Australia

    Background/Purpose: Prevention of organ damage is one of the main treatment goals in systemic lupus erythematosus (SLE).The SLICC/ACR Damage Index (SDI) is used to quantify…
  • Abstract Number: 2071 • ACR Convergence 2022

    The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC), American College of Rheumatology (ACR), and Lupus Foundation of America (LFA) Damage Index Revision – Item Generation Phase

    Burak Kundakci1, Megan R W Barber2, Ann E Clarke2, Sindhu R. Johnson3, Hermine Brunner4, Jiacai Cho5, Nathalie Costedoat-Chalumeau6, Ellen M. Ginzler7, John Hanly8, Abida Hasan7, Murat İnanç9, Naureen Kabani7, Alexandra Legge10, Kaitlin Lima11, Livia Lindoso12, Anselm Mak13, Rosalind Ramsey-Goldman11, Guillermo Ruiz-Irastorza14, Clovis A. Silva12, Farah Tamirou15, Vitor C. Trindade12, Evelyne Vinet16 and Ian N. Bruce1, 1Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom, 2University of Calgary, Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada, 3Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Department of Pediatrics, Cincinnati, OH, 5National University Health System (NUHS), Singapore, Singapore, 6Inserm DR Paris 5, Paris, France, 7SUNY Downstate Health Sciences University, Department of Medicine, Brooklyn, NY, 8Division of Rheumatology, Queen Elizabeth II Health Sciences Center (Nova Scotia Rehabilitation Site) and Dalhousie University, Halifax, NS, Canada, 9Istanbul University Faculty of Medicine, Istanbul, Turkey, 10Arthritis Research Canada, Dalhousie University, Halifax, NS, Canada, 11Northwestern University Feinberg School of Medicine, Chicago, USA, Chicago, IL, 12Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil, 13Division of Rheumatology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 14Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Spain, 15Rheumatology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 16McGill University Health Centre, Montréal, QC, Canada

    Background/Purpose: The SLICC, ACR and LFA embarked on a data- and expert-driven project to develop a revised systemic lupus erythematosus (SLE) organ damage index (SDI).…
  • Abstract Number: 2089 • ACR Convergence 2022

    The Implication of Skin Involvement on Health-Related Quality of Life (HRQoL) in Systemic Lupus Erythematosus (SLE) Patients

    Alicia Van1, Vibeke Strand2, Jiandong Su1, Nicole Anderson1, Cheryl F Rosen3, Sherief Marzouk4, Lee S Simon5 and Zahi Touma1, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2Stanford University School of Medicine, Stanford, CA, 3University of Toronto, Toronto, ON, Canada, 4University Health Network, University of Toronto, Toronto, ON, Canada, 5SDG LLC, West Newton, MA

    Background/Purpose: Skin involvement in Systemic Lupus Erythematosus (SLE) occurs in 50-85% of patients making it one of the most commonly affected organs in SLE. Previous…
  • Abstract Number: PP17 • ACR Convergence 2022

    Engaging with the Spoon Theory: How I Make Decisions Using a Cost-Benefit Analysis That Works to Improve My Mental Health While Living with RA

    Stephanie Aleite, AiArthritis, St. Louis, MO

    Background/Purpose: Patients living with rheumatoid arthritis (RA) often also live with comorbid mental health conditions. Regardless of diagnosed mental health condition, living with a chronic…
  • Abstract Number: 0098 • ACR Convergence 2022

    Delays in Access to Specialized Care and Diagnosis in Patients with Systemic Lupus Erythematosus

    Alain Sanchez-Rodriguez1, Jose A Meade-Aguilar2, Jeffrey X. Yang2, Gabriel Figueroa Parra2, Shirley-Ann Osei-Onomah2, Rachel Giblon3, Hannah Langenfeld4, Alanna Chamberlain2, Cynthia Crowson5 and Ali Duarte-Garcia2, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Rochester, MN, Rochester, MN, 4Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 5Mayo Clinic, Eyota, MN

    Background/Purpose: Delays in access to specialized care and diagnosis of systemic lupus erythematosus (SLE) are associated with poor outcomes. Prior studies rely mostly on cross-sectional…
  • Abstract Number: 0071 • ACR Convergence 2021

    Damage Accrual Measured by DIAPS in Antiphospholipid Antibody (aPL)-positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Gustavo Balbi1, Yasaman Ahmadzadeh2, Maria Tektonidou3, Vittorio Pengo4, Savino Sciascia5, Amaia Ugarte6, H. Michael Belmont7, Maria Gerosa8, Paul R Fortin9, Chary lopez-pedrera10, Lanlan Ji11, Tatsuya Atsumi12, Hannah Cohen13, Guilherme Ramires de Jesus14, D. Ware Branch15, Cecilia Nalli16, Nina Kello17, Michelle Petri18, Esther Rodriguez-Almaraz19, Giuseppe Barilaro20, Jason Knight21, Bahar Artim-Esen22, Rohan Willis23, Maria Laura Bertolaccini24, Robert Roubey25, Doruk Erkan2, Danieli De Andrade1 and on Behalf of APS ACTION2, 1University of São Paulo, São Paulo, Brazil, 2Hospital for Special Surgery, New York, NY, 3FORZAFORTE HELLAS LTD, Athens, Greece, 4Padova University Hospital, Padova, Italy, 5University of Turin, Turin, Italy, 6Hospital Universitario Cruces, Barakaldo, Spain, 7NYU School of Medicine, New York, NY, 8University of Milan, Milan, Italy, 9CHU de Quebec - Universite Laval, Québec City, QC, Canada, 10IMIBIC/Reina Sofia Hospital/University of Córdoba, Córdoba, Spain, 11Peking University First Hospital, Beijing, China (People's Republic), 12Hokkaido University, Sapporo, Japan, 13Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom, 14Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 15University of Utah, Salt Lake City, UT, 16ASST SPEDALI CIVILI DI BRESCIA, Brescia, Italy, 17Zucker School of Medicine at Hofstra/Northwell Health, Manhasset, NY, 18Johns Hopkins University School of Medicine, Baltimore, MD, 19Hospital Universitario 12 de Octubre, Madrid, Spain, 20Clínic Barcelona - Hospital Universitari, Barcelona, Spain, 21University of Michigan, Ann Arbor, MI, 22Istanbul University School of Medicine, İstanbul, Turkey, 23University of Texas Medical Branch, Galveston, TX, 24King's College London, London, United Kingdom, 25University of North Carolina, Chapel Hill, NC

    Background/Purpose: Damage Index in APS (DIAPS) is a scoring system developed to assess long-term damage in thrombotic primary antiphospholipid syndrome (PAPS), which also correlates with…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences